Your search returned 6 results.

Results
	1.	Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL). [electronic resource] by Hanlon, Katy Rudin, Claudius E Harries, Lorna W Producer: 20100201 In: PloS one vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Osteitis fibrosa cystica and secondary hyperparathyroidism in multiple myeloma. [electronic resource] by Bains, Margaret A Pardoe, Linda E Rudin, Claudius E Producer: 20070328 In: British journal of haematology vol. 136 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Evaluation of 13q14 status in multiple myeloma by digital single nucleotide polymorphism technology. [electronic resource] by Hanlon, Katy Harries, Lorna W Ellard, Sian Rudin, Claudius E Producer: 20091103 In: The Journal of molecular diagnostics : JMD vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Evaluation of 13q14 status in patients with chronic lymphocytic leukemia using single nucleotide polymorphism-based techniques. [electronic resource] by Hanlon, Katy Ellard, Sian Rudin, Claudius E Thorne, Susan Davies, Teresa Harries, Lorna W Producer: 20091014 In: The Journal of molecular diagnostics : JMD vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320. [electronic resource] by Townsend, William Johnson, Rod J Pottinger, Bryson T Counsell, Nicholas Smith, Paul Chadwick, Humra Evans, Katy Wickham, Caroline Rudin, Claudius E Producer: 20180319 In: Leukemia & lymphoma vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal. [electronic resource] by Tikhonova, Irina A Hoyle, Martin W Snowsill, Tristan M Cooper, Chris Varley-Campbell, Joanna L Rudin, Claudius E Mujica Mota, Ruben E Producer: 20171030 In: PharmacoEconomics vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)